Geneos Wealth Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Geneos Wealth Management's OGN Position: Q3 2026 in Review
Geneos Wealth Management increased its Organon & Co (OGN) stake by 38% in Q3 2026, buying an estimated $2.81K and bringing the position to 743 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2378.
Geneos Wealth Management first reported a position in OGN in Q1 2022 and has held it in 19 quarters since. The position peaked at $131K in Q1 2022. 359 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Geneos Wealth Management held 743 shares of Organon & Co worth $10.2K as of Q3 2026.
- Geneos Wealth Management bought 206 Organon & Co shares in Q3 2026, an estimated $2.81K.
- Organon & Co made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2378 holding.
- Geneos Wealth Management first reported a position in Organon & Co in Q1 2022 and has held it in 19 quarters since.
- Geneos Wealth Management's Organon & Co position peaked at $131K in Q1 2022.
- 359 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.